January 28, 2022

Volume XII, Number 28

Advertisement
Advertisement

January 28, 2022

Subscribe to Latest Legal News and Analysis

January 27, 2022

Subscribe to Latest Legal News and Analysis

January 26, 2022

Subscribe to Latest Legal News and Analysis

January 25, 2022

Subscribe to Latest Legal News and Analysis
Advertisement

New FDA Draft Guidance Regarding Financial Disclosures by Clinical Investigators

New recommendations recently released by the FDA demonstrate the changing environment for conflicts of interest management and emphasize the need for pharmaceutical companies, medical device manufacturers and health care providers to ensure they have internal processes that adequately anticipate and meet the baseline requirements.

 

Please click here to view the entire White Paper in Adobe PDF format.
(Adobe Acrobat Reader required, available for free download here)

© 2022 McDermott Will & EmeryNational Law Review, Volume I, Number 192
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

Jennifer S. Geetter, McDermott Will & Emery LLP, Attorney
Partner

Jennifer S. Geetter is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm's Washington, D.C., office.  She focuses her practice on emerging biotechnology and safety issues, advising hospital, industry, insurance and provider clients on matters relating to research, drug and device development, off-label use, personalized medicine, formulary compliance, privacy and security, electronic health records and data strategy initiatives, patient safety, conflicts of interest, scientific review and research misconduct, internal hospital disciplinary proceedings,...

202 756 8205
Advertisement
Advertisement
Advertisement